-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Kelun Pharmaceutical has good news again and again.
On April 7, the clinical application of KL590586 capsule, a new class 1 drug of Sichuan Kelun Botai, a subsidiary of Kelun Pharmaceutical, was accepted by CDE, with the acceptance numbers CXHL2101023 and CXHL2101024.
On April 8, the official website of NMPA showed that Kelun Pharmaceutical's alanyl glutamine injection passed the consistency evaluation.
In terms of generic drugs, Kelun Pharmaceutical has ushered in a harvest period.
Kelun Pharmaceutical is approving varieties
Source: Meinenet MED2.
Moxifloxacin hydrochloride eye drops is a fourth-generation quinolone broad-spectrum antibacterial drug.
Ropivacaine Hydrochloride Injection is a new long-acting amide local anesthetic developed by AstraZeneca, and it is the leading drug in the local anesthetic market.
According to data from Minai.
Source: Minet database